Clinicopathologic Significance of Nuclear Factor-κB and Vascular Endothelial Growth Factor Expression in Advanced Gastric Cancer Patients
Authors:
- Su-Jin KimSKSu-Jin Kim
- Sung Yong OhSOSung Yong Oh
- 20 March 2014
- journal article
- Published by S. Karger AG in Oncology Research and Treatment
- Vol. 37 (4) , 183-190
Abstract
Background: Nuclear factor-κB (NF-κB) and vascular endothelial growth factor (VEGF) are involved in cell proliferation, invasion, angiogenesis, and metastasis. The principal objective of this study was to assess the prognostic significance of NF-κB and VEGF expression in gastric cancer. Methods: Tumor tissues of 154 patients with gastric cancer, all of whom underwent potentially curative resection, were immunohistochemically evaluated using monoclonal antibodies against NF-κB and VEGF. Results: The positivity rates of NF-κB and VEGF staining were 44.2% and 39.6%, respectively. NF-κB expression in tumor tissues was significantly correlated with VEGF expression (p < 0.001). VEGF expression was related to Lauren's classification (p = 0.002), differentiation (p = 0.043), depth of invasion (p = 0.005), carcinoembryonic antigen expression (p = 0.032), and stage (p = 0.026). Univariate analysis demonstrated that NF-κB expression was significantly related to both the 5-year disease-free survival (65.2% vs. 46.4%, p = 0.007) and the 5-year overall survival (60.0% vs. 42.5%, p = 0.014). Multivariate analysis verified that NF-κB was independently associated with disease-free survival (hazard ratio: 2.082, p = 0.005) and overall survival (hazard ratio: 1.841, p = 0.008). Conclusion: NF-κB expression in tumor tissue is associated with poor survival in gastric cancer patients.Keywords
This publication has 26 references indexed in Scilit:
- Molecular Targeted Agents for Gastric Cancer: A Step Forward Towards Personalized TherapyCancers, 2013
- The complexity of NF-κB signaling in inflammation and cancerMolecular Cancer, 2013
- Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2008Cancer Research and Treatment, 2011
- A hypoxia-dependent upregulation of hypoxia-inducible factor-1 by nuclear factor-κB promotes gastric tumour growth and angiogenesisBritish Journal of Cancer, 2010
- Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trialThe Lancet, 2010
- Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008International Journal of Cancer, 2010
- Phase II study of sunitinib as second-line treatment for advanced gastric cancerInvestigational New Drugs, 2010
- Constitutive NF-κB Activation in Colorectal Carcinoma Plays a Key Role in Angiogenesis, Promoting Tumor GrowthClinical Cancer Research, 2009
- No Association of Vascular Endothelial Growth Factor-A (VEGF-A) and VEGF-C Expression with Survival in Patients with Gastric CancerCancer Research and Treatment, 2009
- Clinicopathologic significance of HIF-1α, p53, and VEGF expression and preoperative serum VEGF level in gastric cancerBMC Cancer, 2008